Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.

Abstract

AIM:

To determine if a regimen with prandial + basal insulin compared with basal insulin attenuates post-meal inflammatory and glycative biomarkers in patients with Type 2 diabetes.

METHODS:

This test-meal sub-study in the USA is from a previously reported clinical trial comparing the effect on glycaemic control of 24 weeks of thrice-daily pre-meal insulin lispro mix 50 (50% insulin lispro, 50% insulin lispro protamine suspension) or bedtime insulin glargine, both plus metformin. In the sub-study, glucose, insulin, triglycerides, high-sensitivity C-reactive protein, tumour necrosis factor α, interleukin-6, methylglyoxal and 3-deoxyglucosone were measured during the post-meal period of a mixed-meal breakfast at the final visit. Prandial + basal (n = 25) and basal (n = 21) insulin were administered at the same times as during the previous 24 weeks.

RESULTS:

Post-meal, the prandial + basal insulin group had significantly higher insulin, lower glucose and triglycerides, as well as lower high-sensitivity C-reactive protein, tumour necrosis factor α and interleukin-6, than the basal insulin group. Glucose incremental area under the concentration curve significantly correlated with high-sensitivity C-reactive protein, tumour necrosis factor α, interleukin-6, methylglyoxal and 3-deoxyglucosone incremental area under the concentration curve. Insulin incremental area under the concentration curve correlated inversely with high-sensitivity C-reactive protein and tumour necrosis factor α incremental area under the concentration curve. However, after adjusting for glucose incremental area under the concentration curve, these inverse correlations were no longer significant. Triglyceride incremental area under the concentration curve was not correlated with any biomarker incremental area under the concentration curve.

CONCLUSIONS:

Controlling post-meal hyperglycaemia with prandial + basal insulin in patients with Type 2 diabetes attenuates meal-induced increases in high-sensitivity C-reactive protein, interleukin-6 and tumour necrosis factor α compared with basal insulin. The rise in post-meal glucose, but not triglycerides, significantly correlated with the rise in post-meal inflammatory and glycative biomarkers.

• Authors: P J Beisswenger, W V Brown, A Ceriello, N A Le, R B Goldberg, J P Cooke, D C Robbins, S Sarwat, H Yuan, C A Jones, M H Tan, IOOI Study Investigators
• Journal: Diabetic medicine : a journal of the British Diabetic Association (Diabet Med) Vol. 28 Issue 9 Pg. 1088-95 (Sep 2011) ISSN: 1464-5491 [Electronic] England
• PMID: 21517955 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
• Copyright: © 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Chemical References

• Glycated Hemoglobin A
• Hypoglycemic Agents
• Insulin
• Insulin, Long-Acting
• Interleukin-6
• Tumor Necrosis Factor-alpha
• C-Reactive Protein

Topics

• Adult
• Aged
• C-Reactive Protein (metabolism)
• Diabetes Mellitus, Type 2 (drug therapy, metabolism)
• Female
• Glycated Hemoglobin
• Humans
• Hyperglycemia (drug therapy, metabolism)
• Hypoglycemic Agents (pharmacology, therapeutic use)
• Insulin (analogs & derivatives, pharmacology, therapeutic use)
• Insulin, Long-Acting
• Interleukin-6 (metabolism)
• Male
• Middle Aged
• Postprandial Period
• Treatment Outcome
• Tumor Necrosis Factor-alpha (metabolism)
• United States